“borderline significant”

In the worst-case scenario, all excluded patients were assumed to experience UNOs, yielding a borderline significant increase in UNO risk for RTS compared to LTS (RR 1.09; 95% CI 1.00–1.19; p = 0.05; I 2 = 33%; Fig.

After adjusting for these three variables, the odds of live birth omission were 2.0 times greater for birth histories than for pregnancy histories and this was borderline significant ( p = 0.050).

Individuals randomized to receive azathioprine did not see a reduction in the need for lid surgery (OR = 0.60; 95% CI .12, 3.04; P = .54); however, a borderline significant result was observed for radiotherapy (OR = 0.17; 95% CI .03, 1.03; P = .05) with the 95% CI crossing equality (Supplementary Table 3) ( 27 ).

For the MTRR A66G polymorphism, we detected a borderline significant interaction between this polymorphism and overweight/obesity on serum HDL-C levels ( P = 0.050, Table 3 ).

For hamstrings, the pooled effect was smaller and borderline significant (SMD = 1.48 [− 0.01, 2.97], Z = 1.94, p = 0.05; I 2 = 81%), indicating variability across studies.

Baseline correlation of CMR parameters and EAT EAT was positively correlated with LV mass ( r = 0.25, p = 0.01) and showed a borderline significant association with LVEF ( r = 0.2, p = 0.05).

This study found that patients with CeD, younger-onset diabetes, MS, asthma, and SLE were at higher risk of ALS, and the rate ratio for UC was borderline significant ( P = 0.05), and no significant difference was found for RA, psoriasis and CD.

However, higher cIMT at baseline had a borderline significant association with higher LVDF at follow-up ( p = 0.05). 3.4.

GPx did not show any association with AITDs, but selenium showed a borderline significant ( p = 0.05) association with a lower probability of GD: OR 0.98 (95%CI 0.95–1.00).

In addition, hsCRP levels decreased after T&A (3.12±1.22 to 2.23±1.17 mg/dl ; p<0.01), but improvements in HOMA-IR were only borderline significant (2.1±0.9 to 1.7±0.8; p<0.05).

Moreover, in a prospective randomized, double-blind, placebo-controlled trial enrolling 106 patients with both NAFLD and T2DM who were assigned to receive empagliflozin 10 mg ( n = 35), pioglitazone 30 mg ( n = 34), or placebo ( n = 37) for 24 weeks, only a borderline significant decrease in CAP score was observed with empagliflozin compared with placebo (−29.6 dB/m (−39.5 to −19.6) vs. −16.4 dB/m (−25.0 to −7.8), respectively; p = 0.05) [ 39 ].

Better performance was noted on the CE-SDCT with a borderline significant difference (P = 0.05) for senior radiology resident.

Acute lower respiratory symptoms were associated with lower CCL17 [estimate: 0.6 pg/ml, (95% CI: 0.5–0.8), p < 0.001] and a borderline significant lower level of CCL20 [estimate: 0.5 pg/ml (95% CI: 0.2–1.0), p = 0.05] ( Table 4 ).

SBP was borderline significant for predicting adverse CV events (p = 0.05).

There was a borderline significant association between getting biological treatment and having erosions (OR = 3.61, 95% CI: 1.04–14.45, p = 0.050) and a significant association between biological treatment and having moderate/severe DAS28-CRP (OR = 35.83, 95% CI: 10.18–164.94, p < 0.001).

The difference in neuron/neurotransmission score between the Sham and NRL groups was borderline significant (−0.4 ± 1.5 vs −4.0 ± 0.9, p = 0.050).

Regression analysis The univariable linear regression tests between AUC of post-meal SBP and age, BMI, sex, supine SBP, sinus arrhythmia ratio, the index ∆HR/∆BP and HR during phase IV of VM did not show any significant association, Table 3 ; however, the diagnosis (MSA or PD) had a borderline significant association with AUC of post-meal SBP ( P = 0.05).

The online ward, but not the F2F or control wards showed increased number of good diabetes days (GDD) from median (IQR) 4.7 (2.7–7.0) at baseline/rollout to 6.0 (2.3–7.0) in the post-intervention phase ( p = 0.04), along with increased hypos treated appropriately by ward staff (80% vs 85%, p = 0.026) and total hypos (10% vs 16%, p = 0.043), while severe hypos was borderline significant (3% vs 6%, p = 0.05).

The spline function provided a significantly improved curve-fit in comparison to a linear function for MOF ( p = 0.01), but the improvement was only borderline significant for hip fracture ( p = 0.05).

After adjustment for age, a significant f E/I difference between TSC and TDC remained [ F (1,36) = 6.79, p = 0.01, partial η 2 = 0.16], and the difference in absolute power became borderline significant [ F (1,36) = 4.0, p = 0.05, partial η 2 = 0.1].

Intermittent opioid use appeared to be associated with decreased memory CD8+ T cells proportion (CD45RO+CD45RA- CD8+ T cells: adjusted mean difference [AMD] [95% CI] = -6.15 [-11.50, -0.79], p = 0.02) and borderline significant increased senescent T cells (%CD57+ of total CD28-CD8+ T cells (AMD [95% CI] = 7.70 [-0.06, 15.46], p = 0.05).

In patients with EoE, we observed a moderate inverse correlation between FLIP diameter and PEESS Child Dysphagia (r=‐0.34, p=0.015) and borderline significant weak‐moderate inverse trend between FLIP diameter and PEESS Parent Dysphagia (r=‐0.27, p=0.05).

However, catecholamine status at the ET was borderline significant for OS ( P = .05; Fig 3 J).

Regarding the interaction variable including Space no significant effect was seen for men, and the positive departure from additivity effect was borderline significant for women ( p = 0.05, RERI = −0.57, 95% CI = −1.13 to −0.01).

The difference in mean triglyceride level in the placebo group was not significant after the intervention, although there was a borderline significant difference in the intervention group (p=0.05); nevertheless, the changes in mean triglyceride level between the two groups did not indicate a significant difference.